iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company has a collaboration with Zafe Care Systems AB and Sensorem AB. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. The company was incorporated in 2008 and is headquartered in Stockholm, Sweden.
Metrics to compare | IZAFEb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIZAFEbPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.9x | −3.0x | −0.6x | |
PEG Ratio | 0.10 | 0.02 | 0.00 | |
Price/Book | 4.0x | 3.6x | 2.6x | |
Price / LTM Sales | 9.9x | 2.7x | 3.1x | |
Upside (Analyst Target) | - | 43.3% | 55.2% | |
Fair Value Upside | Unlock | 13.5% | 9.8% | Unlock |